MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection

Oncotarget

Volumn 7, Issue 9, 2016, Pages 10663-10675

  Chang, Pi Yueh ^a,b   Chen, Chia Chun ^b   Chang, Yu Sun ^b   Tsai, Wen Sy ^a   You, Jeng Fu ^a   Lin, Geng Ping ^a   Chen, Ting Wen ^b   Chen, Jinn Shiun ^a   Chan, Err Cheng ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Colorectal cancer; MicroRNA; MiR 223; MiR 92a; Stool

Indexed keywords

EDETIC ACID; MICRORNA; MICRORNA 106B; MICRORNA 10B; MICRORNA 141; MICRORNA 16; MICRORNA 18A; MICRORNA 191; MICRORNA 20A; MICRORNA 221; MICRORNA 223; MICRORNA 24; MICRORNA 25; MICRORNA 31; MICRORNA 497; MICRORNA 92A; UNCLASSIFIED DRUG; MIRN223 MICRORNA, HUMAN; MIRN92 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; BLOOD ANALYSIS; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; FALSE POSITIVE RESULT; FECES ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; BLOOD; COLORECTAL NEOPLASMS; DNA MICROARRAY; GENETICS; OCCULT BLOOD; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRORNAS; MIDDLE AGED; OCCULT BLOOD; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES;

EID: 84961662014     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.7119     Document Type: Article

References (29)

1. Siegel R, DeSantis C and Jemal A. Colorectal cancer statistics, 2014. CA: A Cancer Journal for Clinicians. 2014; 64:104-117
2. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL. Genetic Alterations during Colorectal-Tumor Development. N Engl J Med. 1988; 319:525-532
3. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, Dash C, Giardiello FM, Glick S, Levin TR, Pickhardt P, Rex DK, Thorson A and Winawer SJ. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA: A Cancer Journal for Clinicians. 2008; 58:130-160
4. Whitlock EP, Lin JS, Liles E, Beil TL and Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Annals of internal medicine. 2008; 149:638-658
5. Pawa N, Arulampalam T and Norton JD. Screening for colorectal cancer: established and emerging modalities. Nature Reviews Gastroenterology & Hepatology. 2011; 8:711-722
6. Imperiale TF. Noninvasive screening tests for colorectal cancer. Digestive diseases. 2012; 30 Suppl 2:16-26
7. Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nature Reviews Molecular Cell Biology. 2005; 6:376-385
8. Calin GA and Croce CM. MicroRNA signatures in human cancers. Nature Reviews Cancer. 2006; 6:857-866
9. Catto JWF, Alcaraz A, Bjartell AS, De Vere White R, Evans CP, Fussel S, Hamdy FC, Kallioniemi O, Mengual L, Schlomm T and Visakorpi T. MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review. European Urology. 2011; 59:671-681
10. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell research. 2008; 18:997-1006
11. Pinatel EM, Orso F, Penna E, Cimino D, Elia AR, Circosta P, Dentelli P, Brizzi MF, Provero P and Taverna D. miR-223 is a coordinator of breast cancer progression as revealed by bioinformatics predictions. PLoS One. 2014; 9:e84859
12. Zhang J, Luo X, Li H, Yue X, Deng L, Cui Y and Lu Y. MicroRNA-223 functions as an oncogene in human colorectal cancer cells. Oncology Reports. 2014; 32:115-120
13. Peeters M, Oliner KS, Parker A, Siena S, Van Cutsem E, Huang J, Humblet Y, Van Laethem JL, Andre T, Wiezorek J, Reese D and Patterson SD. Massively Parallel Tumor Multigene Sequencing to Evaluate Response to Panitumumab in a Randomized Phase III Study of Metastatic Colorectal Cancer. Clinical Cancer Research. 2013; 19:1902-1912
14. Zheng G, Du L, Yang X, Zhang X, Wang L, Yang Y, Li J and Wang C. Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma. Br J Cancer. 2014; 111:1985-1992
15. Yang X, Zeng Z, Hou Y, Yuan T, Gao C, Jia W, Yi X and Liu M. MicroRNA-92a as a potential biomarker in diagnosis of colorectal cancer: a systematic review and meta-analysis. PLoS ONE [Electronic Resource]. 2014; 9:e88745
16. Lee Cheng Phua XPC, Poh Koon Koh, Peh Yean Cheah, Eric Chun Yong Chan, Han Kiat Ho. Global fecal microRNA profiling in the identification of biomarkers for colorectal cancer screening among Asians. Oncology reports. 2014; 32:97-104
17. Ahmed FE, Ahmed NC, Vos PW, Bonnerup C, Atkins JN, Casey M, Nuovo GJ, Naziri W, Wiley JE, Mota H and Allison RR. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle. Cancer Genomics & Proteomics. 2013; 10:93-113
18. Wu CW, Ng SS, Dong YJ, Ng SC, Leung WW, Lee CW, Wong YN, Chan FK, Yu J and Sung JJ. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Gut. 2012; 61:739-745
19. Ogata-Kawata H, Izumiya M, Kurioka D, Honma Y, Yamada Y, Furuta K, Gunji T, Ohta H, Okamoto H, Sonoda H, Watanabe M, Nakagama H, Yokota J, Kohno T and Tsuchiya N. Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS ONE [Electronic Resource]. 2014; 9:e92921
20. Duttagupta R, Jiang R, Gollub J, Getts RC and Jones KW. Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS One. 2011; 6:e20769
21. Kirschner MB, Edelman JJ, Kao SC, Vallely MP, van Zandwijk N and Reid G. The Impact of Hemolysis on Cell-Free microRNA Biomarkers. Frontiers in genetics. 2013; 4:94
22. Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, Miyaji MM, Tait JF and Tewari M. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer prevention research. 2012; 5:492-497
23. Koga YY, Masahiro. Takahashi, Amane. Kuroda, Junichiro. Moriya, Yoshihiro. Akasu, Takayuki. Fujita, Shin. Yamamoto, Seiichiro. Baba, Hideo. Matsumura, Yasuhiro. MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. Cancer prevention research. 2010; 3:1435-1442
24. Wu CW, Ng SC, Dong Y, Tian L, Ng SS, Leung WW, Law WT, Yau TO, Chan FK, Sung JJ and Yu J. Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma. Clinical cancer research: an official journal of the American Association for Cancer Research. 2014; 20:2994-3002
25. Yamazaki N, Koga Y, Yamamoto S, Kakugawa Y, Otake Y, Hayashi R, Saito N and Matsumura Y. Application of the fecal microRNA test to the residuum from the fecal occult blood test. Japanese journal of clinical oncology. 2013; 43:726-733
26. Singhal S, Changela K, Basi P, Mathur S, Reddy S, Momeni M, Krishnaiah M and Anand S. Prescreening with FOBT Improves Yield and Is Cost-Effective in Colorectal Screening in the Elderly. ISRN Gastroenterol. 2014; 2014:179291
27. Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, Ahlquist DA and Berger BM. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014; 370:1287-1297
28. Edge S, Byrd, D.R., Compton, C.C., Fritz, A.G., Greene, F.L., Trotti, A. . AJCC Cancer Staging Manual, 7th ed. 2010:649 pages
29. Chen C. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Research. 2005; 33:e179-e179